Table 2. Characteristics of 35 CAP patients with or without coccidioidomycosis, Phoenix, Arizona, USA, 2000–2004*.
Characteristic | No. patients |
p value | |
---|---|---|---|
With coccidioidomycosis (n = 6†) | Without coccidioidomycosis (n = 29†) | ||
Age, y, mean (range) | 59.2 (38.0–80.3) | 67.8 (61.8–73.8) | 0.25 |
Male sex | 2 (33) | 13 (45) | 0.60 |
White race |
6 (100) |
27 (93) |
0.50 |
Location where evaluated | |||
Hospital | 4 (67) | 20 (69) | 0.99 |
Emergency department | 1 (17) | 3 (10) | 0.55 |
Outpatient clinic |
1 (17) |
6 (21) |
0.99 |
Signs and symptoms | |||
Cough | 4 (67) | 27 (93) | 0.12 |
Sputum production | 1 (17) | 16 (55) | 0.18 |
Dyspnea | 6 (100) | 18 (62) | 0.21 |
Fever | 5 (83) | 21 (72) | 0.99 |
Chills | 3 (50) | 11 (38) | 0.98 |
Night sweats | 2 (33) | 7 (24) | 0.99 |
Rash |
3 (50) |
0 |
0.002 |
Chest radiograph findings | |||
Unilateral infiltrates | 5 (83) | 17 (59) | 0.50 |
Bilateral infiltrates |
1 (17) |
8 (28) |
0.96 |
Laboratory results | |||
Leukocyte count, ×109 cells/L, mean (range) | 15.1‡ (9.1–21.2) | 11.0§ (9.1–12.9) | 0.07 |
Absolute eosinophil count, ×109 cells/L, mean (range) |
2.96¶ (0.18–13) |
0.12# (0.0–0.2) |
0.32 |
Empiric coccidioidal treatment prescribed after initial visit | 1 (17) | 1 (3) | 0.76 |
*CAP, community-acquired pneumonia. Values are no. (%) unless otherwise indicated. †Unless otherwise indicated. ‡n = 6. §n = 25. ¶n = 5. #n = 22.